Abstracts
-
Meeting Abstract (25gaa01)
Heat-dependent adverse drug reactions in patients under diuretic therapy – results from ADRED study
Berres J, Uhlig K, Sommer J, Just KS -
Meeting Abstract (25gaa02)
Versorgungsrealität gynäkologischer Arzneimitteltherapien: Inanspruchnahmen der privaten Krankenvollversicherten 2019-2022
Drebka A, Scholl AJ, Jacke CO, Bachmeier BE -
Meeting Abstract (25gaa03)
District-level differences in opioid prescribing in Germany (2023): results from a population-based study
Enners S, Schlotmann A, Schüssel K, Brueckner G, Jobski K, Langner I, Thiede M, Scholle O -
Meeting Abstract (25gaa04)
Associations between health beliefs and the prevalence of adverse events after COVID-19 vaccinations
Francisca BY, Hitzl W, Thiel KE, Brucker C, Kolb S, Sattler A, Hach I -
Meeting Abstract (25gaa05)
Medication Errors – a Relevant Topic for Nurses in Training
Hagedorn M -
Meeting Abstract (25gaa06)
Medication Safety in Pediatrics: Drug-Related Problems in Patients with Inborn Errors of Metabolism
Harings T, Neininger MP, Eisenhofer S, Thiele AG, Kiess W, Bertsche A, Beblo S, Bertsche T -
Meeting Abstract (25gaa07)
Empowering Pharmacies: The Role of Assisted Telemedical Consultations in Enhancing Patient-Centered COVID-19 Care
Heydarpour R, Bakr G, Krebs J, Fröling E -
Meeting Abstract (25gaa08)
Tocilizumab and Ocrelizumab-related reactions in patients with rare diseases – an analysis of spontaneous reports using the EudraVigilance database
Himmel J, Rottenkolber M, Hellwig K, Kiltz U, Schmiedl S -
Meeting Abstract (25gaa09)
Focus on drug therapy safety – case reports with Methotrexate
Janke FF, Keßler C, Hartmann M, Farker K -
Meeting Abstract (25gaa10)
Anticholinergic Exposure in the German National Cohort (NAKO): Prevalence and Drug Utilization Patterns in Real-World Settings
Könnecke J, Drebka A, Scholl AJ, Bößneck N, Bachmeier BE -
Meeting Abstract (25gaa11)
Herpes zoster – vaccination coverage and incidence of disease
Lappe V, Schubert I, Grandt D -
Meeting Abstract (25gaa12)
Medication use in headaches in children and adolescents: the patients’ and parents’ perspectives
Neininger MP, Budde C, Jeschke S, Bertsche T, Bertsche A -
Meeting Abstract (25gaa13)
Analysis of medication used for abortion in the outpatient setting – results of a nationwide online survey among physicians
Rikl L, Graf K, Maeffert J, Kühn L, Schmiedl S -
Meeting Abstract (25gaa14)
Exploring Pharmacotherapy in Parkinson’s Disease Psychosis: a Mixed-Methods Study
Rose O, Hinteregger T, Trinka E, Igsleder I, Pachmayr J, Clemens S -
Meeting Abstract (25gaa15)
Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus, or chronic kidney disease
Scherkl C, Grytzka J, Rottenkolber M, Dreischulte T, Seidling H, Czock D, Groll A, Meid A -
Meeting Abstract (25gaa16)
Ginkgo biloba L. for Cognitive Impairment in the Context of Polypharmacy and Anticholinergic Burden – Real-World Evidence from Everyday Practice
Scholl AJ, Drebka A, Könnecke J, Bößneck N, Mösges R, Frenzel SB, Bachmeier BE -
Meeting Abstract (25gaa17)
Real-world use of pembrolizumab in Germany: patient characteristics and survival
Scholle O, Kollhorst B, Heinig M, Haug U -
Meeting Abstract (25gaa18)
Effect of a pharmaceutical intervention on the completeness of medication histories upon elective hospital admission in elderly patients
Schulz J, Thürmann P -
Meeting Abstract (25gaa19)
Correlations and Partial Correlations in a 10-Year Trend Between Age, Polypharmacy, and the Number of Patients per Morbidity Related Group in Schleswig-Holstein, With Consideration of the Impact of the COVID-19 Pandemic
Schuster R, Emcke T, Burmester M -
Meeting Abstract (25gaa20)
Error Management in CIRS-NRW
Schwalbe O -
Meeting Abstract (25gaa21)
Trends in antidepressant use in 11 European regions 2018–2022: an interrupted time series analysis of the impact of the COVID-19 pandemic
Selke Krulichová I, Hallberg A, Selke GW, Müller T -
Meeting Abstract (25gaa22)
From manufacturing to patient: Ensuring stability and integrity of frozen faecal microbiota capsules during storage and shipping in the setting of the FRESCO trial
Thürmer M, Linhardt C, Junca H, Steube A, Merkel U, Pieper DH, Kiehntopf M, Stallmach A, Hartmann M -
Meeting Abstract (25gaa23)
Manufacturing frozen double encapsulated faecal microbiota as innovative therapy option for FRESCO-study (long-term transfer of FRozen Encapsulated, multi-donor-Stool for active ulcerative Colitis)
Thürmer M, Linhardt C, Steube A, Merkel U, Stallmach A, Hartmann M -
Meeting Abstract (25gaa24)
Introduction of Biopharmaceuticals in Europe: Early Diffusion Patterns and Data Availability
Veszelei I, Aaltonen K, Selke GW, Langner I, Wettermark B -
Meeting Abstract (25gaa25)
Interprofessional Collaboration in the Medication Process: An Analysis of the AMTS Action Plans since 2007
Vogt B, Thürmann P -
Meeting Abstract (25gaa26)
ALERT – analysis of adverse drug reactions and medication errors in adults in Germany
Weal J, Dubrall D, Kayser C, Albrecht B, Sommer J, Below M, Schmid M, Stingl J, Zenker S, Sachs B -
Meeting Abstract (25gaa27)
(AI-Supported) Use of Observational Data in Regulatory Research
Wicherski J, Peltner J, Becker C, Roethlein C, Russek M, Pfeifer K, Ehrenstein V, Fröhlich H, Furtado C, Tolppanen AM, Haenisch B -
Meeting Abstract (25gaa28)
Use of targeted therapy in non-small-cell lung cancer patients in rural and urban areas of Saxony-Anhalt (2010–2023)
Wittenberg I, Bedir A, Kluttig A, Lacruz ME, Thies S -
Meeting Abstract (25gaa29)
Individual Pharmacotherapy Management (IPM) also identifies risks to drug therapy and patient safety arising from guideline recommendations
Wolf U -
Meeting Abstract (25gaa30)
Individual Pharmacotherapy Management (IPM) with defined electronic patient and medication scores prevents far-reaching multidimensional polypharmacy risks and is universally applicable with AI support
Wolf U
